Cargando…

P593: T-CELL DYSFUNCTION BY PSEUDOHYPOXIA AND AUTOCRINE PURINERGIC SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA

Detalles Bibliográficos
Autores principales:	Montironi, Chiara, F Jacobs, Chaja, Cretenet, Gaspard, Peters, Fleur, Kater, Arnon, Simon-Molas, Helga, Eldering, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428982/ http://dx.doi.org/10.1097/01.HS9.0000969276.84566.9e

Ejemplares similares

T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
por: Montironi, Chiara, et al.
Publicado: (2023)

P595: DEFECTIVE MITOCHONDRIAL METABOLISM IS AT THE BASIS OF T-CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
por: Simon-Molas, Helga, et al.
Publicado: (2023)

T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
por: Peters, Fleur S., et al.
Publicado: (2021)

Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia
por: Kater, Arnon P., et al.
Publicado: (2021)

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
por: Jacobs, Chaja F., et al.
Publicado: (2021)

Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?
por: Haselager, Marco V., et al.
Publicado: (2020)

Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
por: van Attekum, Martijn HA, et al.
Publicado: (2017)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
por: Kluckova, Katarina, et al.
Publicado: (2018)

Role of pseudohypoxia in the pathogenesis of type 2 diabetes
por: Song, Jing, et al.
Publicado: (2019)

Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype
por: Celada, Lucía, et al.
Publicado: (2022)

Macrophage-mediated chronic lymphocytic leukemia cell survival is independent of APRIL signaling
por: van Attekum, MHA, et al.
Publicado: (2016)

An autocrine purinergic signaling controls astrocyte-induced neuronal excitation
por: Shen, Weida, et al.
Publicado: (2017)

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia
por: Delgado, Raquel, et al.
Publicado: (2021)

Chronic lymphocytic leukemia presence impairs antigen-specific CD8(+) T-cell responses through epigenetic reprogramming towards short-lived effectors
por: Martens, Anne W. J., et al.
Publicado: (2023)

Collective invasion induced by an autocrine purinergic loop through connexin-43 hemichannels
por: Khalil, Antoine A., et al.
Publicado: (2020)

CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis
por: van Attekum, Martijn H.A., et al.
Publicado: (2017)

Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?
por: de Weerdt, Iris, et al.
Publicado: (2019)

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
por: Zecchini, Vincent, et al.
Publicado: (2014)

Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
por: Hayashi, Yoshihiro, et al.
Publicado: (2019)

Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology
por: Stergiou, Ioanna E., et al.
Publicado: (2021)

Role of the cystathionine β-synthase / H(2)S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
por: Panagaki, Theodora, et al.
Publicado: (2022)

Prolonged Pseudohypoxia Targets Ambra1 mRNA to P-Bodies for Translational Repression
por: Pourpirali, Somayeh, et al.
Publicado: (2015)

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
por: Martens, Anne W.J., et al.
Publicado: (2022)

593 Chronic Urticaria as First Sign of Sarcoidosis
por: Pérez-Bustamante, María Socorro, et al.
Publicado: (2012)

Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
por: Thus, Yvonne J., et al.
Publicado: (2022)

Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling
por: Hofland, Tom, et al.
Publicado: (2019)

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features
por: van der Straten, Lina, et al.
Publicado: (2021)

Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions
por: Montironi, Chiara, et al.
Publicado: (2021)

Succinate Supplement Elicited “Pseudohypoxia” Condition to Promote Proliferation, Migration, and Osteogenesis of Periodontal Ligament Cells
por: Mao, Huimin, et al.
Publicado: (2020)

Myocardial Adaptation in Pseudohypoxia: Signaling and Regulation of mPTP via Mitochondrial Connexin 43 and Cardiolipin
por: Ferko, Miroslav, et al.
Publicado: (2019)

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
por: Baliakas, Panagiotis, et al.
Publicado: (2022)

Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia
por: van Attekum, M H A, et al.
Publicado: (2017)

December 2021 (vol. 225, no. 6, page 593)
Publicado: (2023)

(593) Utilization of Lung Transplantation in Patients with Covid-19
por: Kashem, A., et al.
Publicado: (2023)

miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma
por: Zhang, Wen Cai, et al.
Publicado: (2019)

HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models
por: Seifert, Verena, et al.
Publicado: (2021)

593. Additional medical expenditures attributable to pneumococcal disease in Japan
por: Fukuda, Haruhisa
Publicado: (2020)

ODP593 Thyroid sarcoidosis: case study and literature review
por: Patadia, Palak, et al.
Publicado: (2022)

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
por: Martens, Anne W J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ea99tfm61npkokm8h6blv3cs1